Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter June 1, 2005

First WHO/IFCC International Reference Reagent for Lipoprotein(a) for Immunoassay – Lp(a) SRM 2B

  • Francesco Dati , Jillian R. Tate , Santica M. Marcovina and Armin Steinmetz

Abstract

Lipoprotein(a) is an important predictor of cardiovascular disease risk. The lack of internationally accepted standardization has impeded the broad application of this lipoprotein in laboratory medicine. The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), through its Working Group on Lipoprotein(a) and together with research institutions and several diagnostic companies, have succeeded in developing an international reference material that is intended for the transfer of a lipoprotein(a) concentration to manufacturers' master calibrators. IFCC SRM 2B has recently been accepted by the WHO Expert Committee on Biological Standardization as the ‘First WHO/IFCC International Reference Reagent for Lipoprotein(a) for Immunoassay’. The assigned unitage of 0.1071 nanomoles of lipoprotein(a) per vial is traceable to the consensus reference method for lipoprotein( a) and will enable conformity by diagnostic companies to the European Union's Directive on In vitro Diagnostic Medical Devices for the metrological traceability of calibrator materials.

Published Online: 2005-6-1
Published in Print: 2004-6-7

Copyright © 2004 by Walter de Gruyter GmbH & Co. KG

Downloaded on 5.3.2024 from https://www.degruyter.com/document/doi/10.1515/CCLM.2004.114/html
Scroll to top button